Information:
Fel:
ID
39578
Beskrivning
Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study; ODM derived from: https://clinicaltrials.gov/show/NCT02220868
Länk
https://clinicaltrials.gov/show/NCT02220868
Nyckelord
Versioner (1)
- 2020-01-31 2020-01-31 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
31 januari 2020
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatitis C Infection NCT02220868
Eligibility Hepatitis C Infection NCT02220868
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C Infection NCT02220868
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
18 years of age or older
boolean
C0001779 (UMLS CUI [1])
Chronic Hepatitis C Genotype
Item
chronic hcv genotype 1 infection
boolean
C0524910 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
C1533728 (UMLS CUI [1,2])
Cobicistat and elvitegravir and emtricitabine and tenofovir
Item
receiving emtricitabine/tenofovir/cobicistat/elvitegravir for at least 8 weeks.
boolean
C3499879 (UMLS CUI [1])
CD4 Count
Item
cd4 count >200 cells/mm3 at screening and no cd4 count <200 in previous 12 weeks
boolean
C0243009 (UMLS CUI [1])
Human Immunodeficiency Virus RNA copies/mL Polymerase Chain Reaction
Item
hiv rna pcr <50 copies/ml at screening and no hiv rna pcr > 200 copies/ml in previous 12 weeks
boolean
C4330330 (UMLS CUI [1,1])
C1531853 (UMLS CUI [1,2])
C0032520 (UMLS CUI [1,3])
C1531853 (UMLS CUI [1,2])
C0032520 (UMLS CUI [1,3])
Integrase Inhibitor Resistance
Item
history of integrase inhibitor resistance
boolean
C0376601 (UMLS CUI [1,1])
C1514892 (UMLS CUI [1,2])
C1514892 (UMLS CUI [1,2])
Integrase Inhibitor Failure
Item
history of integrase inhibitor failure
boolean
C0376601 (UMLS CUI [1,1])
C0231174 (UMLS CUI [1,2])
C0231174 (UMLS CUI [1,2])
Absolute neutrophil count | African Americans
Item
absolute neutrophil counts under 1500/mm3 ( black/ african americans <1200/mm3
boolean
C0948762 (UMLS CUI [1])
C0085756 (UMLS CUI [2])
C0085756 (UMLS CUI [2])
Liver Cirrhosis
Item
patients with cirrhosis
boolean
C0023890 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count under 90,000 per cubic millimeter
boolean
C0032181 (UMLS CUI [1])
Hemoglobin measurement | Gender
Item
hemoglobin levels <11 gm/dl in women or <12 gm/dl in men
boolean
C0518015 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0079399 (UMLS CUI [2])
DIRECT ACTING ANTIVIRALS
Item
previous treatment with a daa
boolean
C3653501 (UMLS CUI [1])
Liver carcinoma
Item
hepatocellular carcinoma
boolean
C2239176 (UMLS CUI [1])
Alpha one fetoprotein measurement
Item
afp>100 ng/ml
boolean
C0201539 (UMLS CUI [1])
Hepatitis B Virus | Hepatitis B surface antigen positive
Item
hepatitis b virus (hbsag positive)
boolean
C0019169 (UMLS CUI [1])
C0149709 (UMLS CUI [2])
C0149709 (UMLS CUI [2])
Decompensated liver disease | Ascites | Bleeding varices | Hepatic Encephalopathy
Item
evidence of decompensated liver disease including, but not limited to, a history of presence of clinical ascites, bleeding varices, or hepatic encephalopathy
boolean
C4075847 (UMLS CUI [1])
C0003962 (UMLS CUI [2])
C0333106 (UMLS CUI [3])
C0019151 (UMLS CUI [4])
C0003962 (UMLS CUI [2])
C0333106 (UMLS CUI [3])
C0019151 (UMLS CUI [4])